000 | 01004 a2200301 4500 | ||
---|---|---|---|
005 | 20250515134415.0 | ||
264 | 0 | _c20080911 | |
008 | 200809s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMc081511 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenberg, Steven A | |
245 | 0 | 0 |
_aCancer immunotherapy. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cSep 2008 |
||
300 |
_a1072 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aCancer Vaccines |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _xtransplantation |
650 | 0 | 4 |
_aMelanoma _xsecondary |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 | _aT-Lymphocytes |
700 | 1 | _aDudley, Mark E | |
700 | 1 | _aRestifo, Nicholas P | |
773 | 0 |
_tThe New England journal of medicine _gvol. 359 _gno. 10 _gp. 1072 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc081511 _zAvailable from publisher's website |
999 |
_c18238919 _d18238919 |